(Q61969376)

English

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

clinical trial

Statements

Myfortic® Monotherapy to Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss (English)
0 references
0 references
January 2009
0 references
January 2022
0 references
18
0 references
18 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit